| CHME Stock | | | USD 0.0002 0.00 0.00% |
EVP
Ms. Minhua Liu is Executive Vice President of China Medicine Corporationration She is no longer Director of the Company effective September 30, 2011. She was Executive Vice President since February 8, 2006 and a Director of the Company since February 10, 2006. She was Vice General Manager of Konzern since July 2000. Prior to that, she had served as a company herbalist doctor for China Military Science Qiming Research Center in Beijing, responsible for all the health care of all staff of the research center since 2011.
| Age | 55 |
| Tenure | 13 years |
| Phone | 86 20 8739 1718 |
| Web | https://www.cmc621.com/cmc/index.php |
Liu obtained her bachelor’s degree from Beijing College of Traditional Chinese Medicine in 1992.
China Medicine Management Efficiency
The company has return on total asset
(ROA) of
0.0782 % which means that it generated a profit of $0.0782 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
0.0663 %, meaning that it created $0.0663 on every $100 dollars invested by stockholders. China Medicine's management efficiency ratios could be used to measure how well China Medicine manages its routine affairs as well as how well it operates its assets and liabilities.
China Medicine currently holds 4.05
M in liabilities with Debt to Equity
(D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. China Medicine has a current ratio of 10.93, suggesting that it is
liquid enough and is able to pay its financial obligations when due. Debt can assist China Medicine until it has trouble settling it off, either with new capital or with free cash flow. So, China Medicine's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like China Medicine sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for China to invest in growth at high rates of return. When we think about China Medicine's use of debt, we should always consider it together with cash and equity.
China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China. CHINA MEDICINE operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 281 people. China Medicine [CHME] is a
Pink Sheet which is traded between brokers over the counter.
Management Performance
China Medicine Leadership Team
Elected by the shareholders, the China Medicine's board of directors comprises two types of representatives: China Medicine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Medicine's management team and ensure that shareholders' interests are well served. China Medicine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Medicine's outside directors are responsible for providing unbiased perspectives on the board's policies.
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is China Medicine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in China Pink Sheet
China Medicine financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Medicine security.